-
admin
Posts
Curevo Raises $110 Million to Advance Amezosvatein Shingles Vaccine
— Amezosvatein has shown excellent immunogenicity and improved tolerability in Phase 2 study — Medicxi leads round, joined by new investors OrbiMed, HBM Healthcare Investments,...
Vidu and Aura Productions Announce Partnership to Debut Sci-Fi Series of AI-Generated Anime Shorts
SINGAPORE, March 17, 2025 /PRNewswire/ — Vidu, the flagship product of ShengShu Technology and a pioneer in generative AI video, is partnering with Aura Productions, a...
Rona Therapeutics Receives IND Clearance from FDA to Initiate Phase 2 Study of RN0361: an APOC3 Targeted siRNA for Management of Hypertriglyceridemia
SHANGHAI, March 17, 2025 /PRNewswire/ — Rona Therapeutics Inc., a global leader in RNA-targeted therapeutics, announced the clearance of an Investigational New Drug (IND) by the...
HERO ESPORTS Asian Champions League: 6 Spots for Esports World Cup Up for Grabs in Teamfight Tactics Tournament
SHANGHAI, March 17, 2025 /PRNewswire/ — The HERO ESPORTS Asian Champions League (ACL), Asia’s premier multi-title esports tournament hosted by Asia’s leading Esports company Hero Esports,...
E Fund: Harnessing AI Trends in China to Drive Innovation and Enhance ETF Offerings
GUANGZHOU, China, March 17, 2025 /PRNewswire/ — The recent AI model developed by DeepSeek has taken the world by surprise and triggered a rally in Chinese...
Chance Pharma Secures New Funding to Accelerate Development of Innovative Inhalation Therapies
HANGZHOU, China, March 17, 2025 /PRNewswire/ — Chance Pharmaceuticals (“Chance Pharma”), a clinical-stage biotechnology company dedicated to the research and development of innovative inhalation therapies, today...
Global Reach for US Biotechs: Avance Clinical Secures MOUs with Four Premier Taiwanese Trial Sites
TAIPEI, Taiwan and ADELAIDE, Australia, March 17, 2025 (GLOBE NEWSWIRE) — Avance Clinical, a leading full-service global Contract Research Organization (CRO) specializing in high-quality, agile...
Dyne Therapeutics Announces New Long-Term Clinical Data from Phase 1/2 DELIVER Trial of DYNE-251 in Duchenne Muscular Dystrophy Demonstrating Unprecedented and Sustained Functional Improvement Through 18 Months
– Continued favorable safety profile for DYNE-251 – – DELIVER Registrational Expansion Cohort is fully enrolled; data from this cohort planned for late 2025 – –...
DentPure Under Review: How Probiotics Help Support Stronger Teeth & Healthier Gums
Harnessing the Power of Probiotics to Combat Bad Breath, Strengthen Enamel, and Support Optimal Oral Health AURORA, Colo., March 16, 2025 (GLOBE NEWSWIRE) — In...
CNOOC Limited Brings On-stream Two New Projects
HONG KONG, March 17, 2025 /PRNewswire/ — CNOOC Limited (the “Company”, SEHK: 00883 (HKD Counter) and 80883 (RMB Counter), SSE: 600938) today announces that Caofeidian...
